Cited by 602Protein Kinase Regulation and GTPase SignalingPhosphodiesterase function and regulationCardiovascular, Neuropeptides, and Oxidative Stress Research

Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle

Open access
Sauzeau, Vincent, Le Jeune, Hélène, Cario-Toumaniantz, Chrystelle, Smolenski, Albert, Lohmann, Suzanne M., Bertoglio, Jacques, Chardin, Pierre, Pacaud, Pierre +1 more·2000·Journal of Biological Chemistry

Abstract

The potent vasodilator action of cyclic GMP-dependent protein kinase (cGK) involves decreasing the Ca(2+) sensitivity of contraction of smooth muscle via stimulation of myosin light chain phosphatase through unknown mechanisms (Wu, X., Somlyo, A. V., and Somlyo, A. P. (1996) Biochem. Biophys. Res. Commun. 220, 658-663). Myosin light chain phosphatase activity is controlled by the small GTPase RhoA and its target Rho kinase. Here we demonstrate cGMP effects mediated by cGK that inhibit RhoA-dependent Ca(2+) sensitization of contraction of blood vessels and actin cytoskeleton organization in cultured vascular myocytes. Ca(2+) sensitization and actin organization were inhibited by both 8-bromo-cGMP and sodium nitroprusside (SNP). SNP also caused translocation of activated RhoA from the membrane to the cytosol. SNP-induced actin disassembly was lost in vascular myocytes in culture after successive passages but was restored by transfection of cells with cGK I. Furthermore, cGK phosphorylated RhoA in vitro, and addition of cGK I inhibited RhoA-induced Ca(2+) sensitization in permeabilized smooth muscle. 8-Bromo-cGMP-induced actin disassembly was inhibited in vascular myocytes expressing RhoA(Ala-188), a mutant that could not be phosphorylated. Collectively, these results indicate that cGK phosphorylates and inhibits RhoA and suggest that the consequent inhibition of RhoA-induced Ca(2+) sensitization and actin cytoskeleton organization contributes to the vasodilator action of nitric oxide.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m000753200

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PKA/PKG-mediated phosphorylation of RhoA on Ser188 inhibits RhoA activity by favoring interaction with RhoGDI, leading to extraction from the plasma membrane, and protects GTP-bound RhoA from ubiquitin-mediated proteasomal degradation.

    “The most well-studied phosphorylation event of RhoA is protein kinase A (PKA) and cyclic GMP-dependent protein kinase (PKG)-mediated phosphorylation on Ser188, close to the prenylated Cys190 in the C-terminus [49,50,56]. This phosphorylation inhibits RhoA activity by favoring interaction with RhoGDI, leading to its extraction from the plasma membrane [50,51,55], and protects GTP-bound RhoA from ub”

    From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [56]

    The ‘cGK Phosphorylates RhoA in Vitro’ passage identifies Ser188 as the PKG phosphorylation site. The Discussion reports that PKG phosphorylation moves activated RhoA from the membrane to the cytosol and recounts earlier work linking PKA phosphorylation to increased RhoGDI interaction. Our copy does not address protection of GTP-bound RhoA from ubiquitin-mediated proteasomal degradation. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 11

  1. [1]1. Somlyo, A.P. Nature. 1997; 389:908-911 Crossref Scopus (34) PubMed Google Scholar
  2. [2]2. Somlyo, A.P. ∙ Somlyo, A.V. Nature. 1994; 372:231-236 Crossref Scopus (1765) PubMed Google Scholar
  3. [3]3. Gong, M.C. ∙ Iizuka, K. ∙ Nixon, G. ... Proc. Natl. Acad. Sci. U. S. A. 1996; 93:1340-1345 Crossref Scopus (269) PubMed Google Scholar
  4. [4]4. Otto, B. ∙ Steusloff, A. ∙ Just, I. ... J. Physiol. (Lond.). 1996; 496:317-329 Crossref Scopus (106) Google Scholar
  5. [5]5. Fujihara, H. ∙ Walker, L.A. ∙ Gong, M.C. ... Mol. Biol. Cell. 1997; 8:2437-2447 Crossref Scopus (144) PubMed Google Scholar
  6. [6]6. Uehata, M. ∙ Ishizaki, T. ∙ Satoh, H. ... Nature. 1997; 389:990-994 Crossref Scopus (2601) PubMed Google Scholar
  7. [7]7. Fu, X. ∙ Gong, M.C. ∙ Jia, T. ... FEBS Lett. 1998; 440:183-187 Crossref Scopus (197) PubMed Google Scholar
  8. [8]8. Togashi, H. ∙ Emala, C.W. ∙ Hall, I.P. ... Am. J. Physiol. 1998; 274:L803-L809 PubMed Google Scholar
  9. [9]9. Hirshman, C.A. ∙ Emala, C.W. Am. J. Physiol. 1999; 21:L653-L661 Google Scholar
  10. [10]10. Furchgott, R.F. Annu. Rev. Pharmacol. Toxicol. 1995; 35:1-27 Crossref PubMed Google Scholar
  11. [11]11. Lohmann, S.M. ∙ Vaandrager, A.B. ∙ Smolenski, A. ... Trends Biochem. Sci. 1997; 22:307-312

Cited by

Sorted by citations

Authors
Sauzeau, V., Le Jeune, H., Cario-Toumaniantz, C., Smolenski, A., Lohmann, S. M., Bertoglio, J., Chardin, P., Pacaud, P., & Loirand, G.
Affiliations
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2000-07
Volume
275
Issue
28
Pages
21722-21729
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2121452261
Cited by
602
References
0
Citations by year
2026: 4 · 2025: 5 · 2024: 3 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 15 · 2019: 5 · 2018: 15 · 2017: 14 · 2016: 12 · 2015: 21 · 2014: 26 · 2013: 25 · 2012: 49
FWCI
12.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
  • Health Sciences › Medicine › Surgery › Cardiovascular, Neuropeptides, and Oxidative Stress Research
Keywords
cGMP-dependent protein kinase, RhoA, Rho kinase, calcium sensitization, vascular smooth muscle contraction, myosin light chain phosphatase, actin cytoskeleton organization, nitric oxide, vasodilation, 8-bromo-cGMP, sodium nitroprusside
MeSH terms
Actins, Animals, Aorta, Calcium, Cells, Cultured, Cytoskeleton, Gallopamil, Cyclic GMP, Guinea Pigs, Isometric Contraction, Muscle, Smooth, Vascular, Nitroprusside, Phenylephrine, Phosphorylation, Portal Vein, Pulmonary Artery, Rabbits, Signal Transduction, Guanosine 5'-O-(3-Thiotriphosphate), Rats, Wistar, Cyclic GMP-Dependent Protein Kinases, Thapsigargin, Calcium Signaling, rhoA GTP-Binding Protein, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review